What is Veracyte's remainder of fiscal year 2025?

Veracyte (VCYT) reported remainder of fiscal year 2025 of $9.39M in Q1 2026.

How has Veracyte's remainder of fiscal year 2025 changed year-over-year?

Veracyte's remainder of fiscal year 2025 decreased by 2.4% year-over-year, from $9.62M to $9.39M.

Veracyte VCYT Remainder of Fiscal Year 2025

Remainder of Fiscal Year 2025 at other companies

Guardant HealthGH

——

Natera, Inc.NTRA

——

RevvityRVTY

——

Agilent TechnologiesA

——

Lantheus HoldingsLNTH

——

Other financials

Income statement

See full

Revenue$139.1M+21.5%

Gross profit$101.2M+27.2%

Operating income$22.6M+680%

Net income$28.7M+307%

EPS (diluted)$0.35+289%

Balance sheet

See full

Cash & equivalents$264.8M+41.0%

Total debt$39.3M-22.1%

Total equity$1.3B+12.5%

Total assets$1.4B+9.2%

Cash flow

See full

Operating cash flow$35.2M+557%

CapEx$3.0M+62.8%

Free cash flow$32.3M+810%

Valuation

See full

Market cap$4.29B+10.7%

Profitability

See full

Gross margin70.9%+2.9pp

Operating margin14.3%+9.2pp

Net margin16.2%+9.1pp

FCF margin28.7%+11.7pp

Returns & leverage

See full

Return on equity6.9%+4.1pp

Debt / equity0×0.0×

Current ratio9.3×+4.2×

Where this comes from

Reported directly by Veracyte in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear.

The official record: Veracyte’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Veracyte's remainder of fiscal year 2025.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Veracyte's remainder of fiscal year 2025?: Veracyte (VCYT) reported remainder of fiscal year 2025 of $9.39M in Q1 2026.
How has Veracyte's remainder of fiscal year 2025 changed year-over-year?: Veracyte's remainder of fiscal year 2025 decreased by 2.4% year-over-year, from $9.62M to $9.39M.